These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 36167400)
1. Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories. Ng HK; Li KK; Chung NY; Chan JY; Poon MF; Wong QH; Kwan JS; Poon WS; Chen H; Chan DT; Shi ZF; Mao Y Brain Pathol; 2023 May; 33(3):e13120. PubMed ID: 36167400 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357 [TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900 [TBL] [Abstract][Full Text] [Related]
4. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular characteristics of pediatric meningiomas. Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666 [TBL] [Abstract][Full Text] [Related]
6. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329 [TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131 [TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212 [TBL] [Abstract][Full Text] [Related]
11. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
12. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247 [TBL] [Abstract][Full Text] [Related]
13. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144 [TBL] [Abstract][Full Text] [Related]
14. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas. Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707 [TBL] [Abstract][Full Text] [Related]
15. Genomic analysis of spinal meningiomas: correlation with histopathological grade. Driver J; Santagata S; Bi WL; Chi JH J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381 [TBL] [Abstract][Full Text] [Related]
16. [Meningioma]. Sasaki H No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334 [TBL] [Abstract][Full Text] [Related]
17. Deletions on chromosome 22 in sporadic meningioma. Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265 [TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345 [TBL] [Abstract][Full Text] [Related]
19. NF2 mutations in secretory and other rare variants of meningiomas. Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management. Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]